Weinnovate Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-07-2024
- Paid Up Capital ₹ 0.15 M
as on 09-07-2024
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 230.52%
(FY 2021)
- Profit -254.46%
(FY 2021)
- Ebitda -279.78%
(FY 2021)
- Net Worth 1139.51%
(FY 2021)
- Total Assets 935.92%
(FY 2021)
About Weinnovate Biosolutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Milind Choudhari, Anupama Engineer, and Prasad Bhagat serve as directors at the Company.
- CIN/LLPIN
U74990PN2016PTC158762
- Company No.
158762
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Weinnovate Biosolutions Private Limited offer?
Weinnovate Biosolutions Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Urological & Obstetrics Instruments, Urinary Catheter.
Who are the key members and board of directors at Weinnovate Biosolutions?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Bhagat  | Director | 25-Apr-2017 | Current |
| Milind Choudhari | Director | 11-Mar-2016 | Current |
| Anupama Engineer | Director | 11-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Weinnovate Biosolutions.
Weinnovate Biosolutions Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 230.52% increase. The company also saw a substantial fall in profitability, with a 254.46% decrease in profit. The company's net worth Soared by an impressive increase of 1139.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Weinnovate Biosolutions?
In 2021, Weinnovate Biosolutions had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Weinnovate Biosolutions?
Weinnovate Biosolutions has a workforce of 6 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Weinnovate Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weinnovate Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
